IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sphera Funds Management Ltd.

Q4 2015 Holdings

Filed 2016-02-11 | 119 holdings | $78.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Gilead Sciences Inc(GILD)COM375558103$14.4K142,7000.0%
Mylan N VCallCALLN59465909$16.2K300,0000.0%
Celgene Corp(CELG)COM151020104$17.6K147,2000.0%
Spdr Series TrustPutPUT78464A950$23.2K329,8000.0%
Allergan PLCSHSG0177J108$31.3K100,0000.0%
Pfizer Inc(PFE)COM717081103$38.0K1,176,6120.0%
Ormat Technologies Inc(ORA)COM686688102$38.7K272,4620.0%
Teva Pharmaceutical Inds LTD(TEVA)ADR881624209$51.5K784,8500.1%
Spdr S&P 500 ETF TRPutPUT78462F953$81.5K400,0000.1%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$388.0K3,7000.5%
Aldeyra Therapeutics Inc(ALDX)COM01438T106$1.6M238,5002.1%
Arbutus Biopharma Corp(ABUS)COM03879J100$2.0M454,5002.6%
Agios Pharmaceuticals Inc(AGIO)COM00847X104$3.2M50,0004.2%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$3.6M100,0004.6%
Catalyst Pharmaceuticals Inc(CPRX)COM14888U101$3.6M1,455,0004.6%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$3.8M40,0004.8%
Abbvie Inc(ABBV)COM00287Y109$21.4M362,00027.4%
Biogen Inc(BIIB)COM09062X103$37.9M123,85048.5%
PreviousPage 3 of 3